Plain-English translation of NCT04979156 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This trial is testing the SOLTIVE™ Thulium laser, a new surgical tool designed to remove bladder tumors in one complete piece rather than in fragments. The goal is to improve how doctors treat bladder cancer by using this laser technology during surgery. Researchers at the University of Kansas are collecting information about how well this approach works and whether it helps patients.
Traditional bladder tumor removal sometimes requires breaking the tumor into pieces during surgery, which can make it harder for doctors to fully examine the cancer and plan follow-up care. This new laser technique aims to remove tumors intact in one piece, which may improve the quality of the surgery and patient outcomes.
You likely qualify if…
You likely don't qualify if…
You will have routine blood tests and imaging before surgery, just as you normally would. During the surgery, your surgeon will use the SOLTIVE™ Thulium laser to carefully remove your bladder tumor in one complete piece. The surgery follows the same general approach and recovery as traditional bladder tumor removal, and your surgeon may switch to a standard technique if needed during the procedure.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
University of Kansas Medical Center
Enrollment target
~20 participants
Started
November 2021
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jane Ledesma
University of Kansas Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.